A short monologue by Dr. Charles Mok discussing minocycline in the context of multiple sclerosis (MS) management. The speaker references a 2018 book and research dating back to about 2014, noting that minocycline — an antibiotic commonly used for acne — penetrates the brain and paradoxically improves gastrointestinal microbiome diversity and richness, which may relate to longer-term responses in MS.
Chapters
What else can we do in addition to that to maybe get a longer term response? Well, in the book, I talk about a few of the things we've discovered with Ms. Or last 10 years or so. I wrote the book in 2018, so using more information since then. But one thing was back in about 2014 or so, they were studying an antibiotic called minocycline. Minocycline is commonly used for acne. It's a antibiotic, one of the few that penetrates into the brain. Interesting. It's one of the few antibiotics that improves the microbiome of the gastrointestinal tract. So most in your gastrointestinal tract or your bowel, you've got multiple bacteria. Most antibiotics are like dropping a time bomb in there, and this really messes that up. Where minocycline scenes improve the diversity and richness, which are the two key components to a healthy gut.